Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Kyowa Kirin Co. Ltd. | KY4 | 26. sep 2024 | 15.90 | -6.47 |
LEES PHARM | L1PA | 26. sep 2024 | 0.13 | -0.79 |
LIVZON PHARMA | LP6 | 26. sep 2024 | 2.92 | +2.10 |
Luye Pharma Group Ltd | LUP | 26. sep 2024 | 0.36 | +2.29 |
Mayne Pharma Group Limited | HG6 | 26. sep 2024 | 2.78 | +2.96 |
Merck KGAA | MRKC | 26. sep 2024 | 31.20 | +1.96 |
MGC Pharmaceuticals Ltd | H5O | 26. sep 2024 | 0.21 | 0.00 |
Mochida Pharmaceutical Co. Ltd. | MFY | 26. sep 2024 | 21.40 | +3.88 |
MPH Health Care AG | 93M1 | 26. sep 2024 | 24.60 | +0.82 |
N4 Pharma plc. | 0GO | 26. sep 2024 | 0.00 | 0.00 |
Otsuka Holdings Co.,Ltd. | OS1 | 26. sep 2024 | 51.00 | +2.82 |
Pharmanutra S.p.A. | 761 | 26. sep 2024 | 58.30 | +0.34 |
Provexis Plc | NZCA | 26. sep 2024 | 0.01 | 0.00 |
Roche Holding AG | RHO6 | 26. sep 2024 | 35.43 | -1.79 |
Santen Pharmaceutical Co. Ltd. | SZD | 26. sep 2024 | 11.10 | +0.91 |
SHANDONG XINHUA | XIN | 26. sep 2024 | 0.60 | +1.69 |
Shield Therapeutics plc | 1JS | 26. sep 2024 | 0.05 | +19.05 |
SHINEWAY PHARM | C1S | 26. sep 2024 | 0.95 | +3.24 |
Shionogi & Co. Ltd. | SH0 | 26. sep 2024 | 39.60 | 0.00 |
SIHUAN PHARM | TEL1 | 26. sep 2024 | 0.06 | +2.59 |
Solasia Pharma K.K. | 9SO | 26. sep 2024 | 0.28 | -2.80 |
Sumitomo Dainippon Pharma Co. Ltd | DPM | 26. sep 2024 | 3.70 | -0.54 |
Takeda Pharmaceutical Co | TKD | 26. sep 2024 | 25.86 | -1.49 |
TILT Holdings Inc | 0T01 | 26. sep 2024 | 0.02 | 0.00 |
Toho Holdings Co. Ltd. | TON | 26. sep 2024 | 29.00 | +2.11 |
TONG REN TANG | TNG | 26. sep 2024 | 0.55 | -3.51 |
Towa Pharmaceutical Co., Ltd. | 6QC | 26. sep 2024 | 19.20 | +1.05 |
UNITED LAB | UNJ | 26. sep 2024 | 0.97 | +5.98 |
Venture Life Group Plc | 17V | 26. sep 2024 | 0.56 | 0.00 |
Willow Biosciences Inc Ordinary Shares | 3D7 | 26. sep 2024 | 0.06 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.